Iovance Biotherapeutics
Stefanie Bulilan is a seasoned professional in the pharmaceutical industry, with extensive experience in quality control and GMP operations. Stefanie has held various leadership roles in companies such as Iovance Biotherapeutics, Arcus Biosciences, BeiGene, Relypsa, BioMarin Pharmaceutical Inc., A.P. Pharma, Tercica Inc., and Anesiva Inc. Stefanie has a BS in Biological Sciences from California State University - East Bay and currently holds the position of Sr. Director Quality Systems and Compliance at Iovance Biotherapeutics. Stefanie's expertise includes managing quality systems, overseeing quality metrics, and providing technical support for GMP operations.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.